TrialNature medicine2024

Fruquintinib plus paclitaxel versus placebo plus paclitaxel for gastric or gastroesophageal junction adenocarcinoma: the randomized phase 3 FRUTIGA trial.

Feng Wang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.